Rod

Pharmacokinetics and Preclinical Development Expert

Summary

Rod is a senior scientific leader with over 25 years of experience in pharmacokinetics, analytical chemistry, and preclinical development. He has supported the advancement of multiple nationally recognized therapeutics, guiding biotech organizations from discovery through IND-enabling studies. Rod brings a pragmatic, cross-functional approach to program leadership, offering deep expertise in bioanalysis, formulation strategy, and regulatory documentation across a range of therapeutic areas.

Core Expertise

  • Pharmacokinetics (PK) and ADME Strategy 
  • Preclinical Program Design and Execution 
  • Bioanalytical Method Development 
  • Formulation and Analytical Chemistry 
  • Regulatory Documentation and IND Preparation 

Career Highlights

Principal Consultant: Leads IND-enabling programs and preclinical strategy across gene therapy, oncology, and rare disease. Oversees CRO partnerships and regulatory documentation. 

Head of DMPK/Analytical Sciences: Directed PK and ADME studies for nanoparticle therapeutics and led global clinical collaborations. 

Head of DMPK: Managed a 20+ person team supporting small molecule and biologics programs. Drove IND transitions and global automation efforts. 

Contact Us Today